Exclusive | He revolutionized clinical trials with AI, and Pure Intelligence completed its first round of Series A funding worth over 100 million yuan.
Summary
Pure Intelligence completed its first Series A financing round, raising more than 100 million yuan. The company focuses on AI-driven clinical trial solutions and positions itself as a platform for end-to-end clinical research workflow management. Its software aims to improve trial efficiency, reduce costs, and support data quality, compliance, and process automation. The article also describes the company's commercialization progress, customer traction, and product modules for clinical trial operations.
Funding
Amount
$14.0M
Total raised
Date
June 30, 2026
Announcement date
Investors
-
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected